Lemaitre Vascular INC Form 4 insider transactions

Director Martha Shadan reports acquiring dividend equivalent rights related to restricted stock units and performance share units in LeMaitre Vascular.

Director John A. Roush reports acquisition of dividend equivalent rights related to restricted stock units and performance share units.

Director Bridget A. Ross reports the acquisition of dividend equivalent rights related to restricted stock units and performance share units.

Director John O'Connor reports the acquisition of dividend equivalent rights related to restricted stock unit and performance share unit awards.

Director Lawrence J. Jasinski acquired dividend equivalent rights related to restricted stock units and performance stock units of Lemaitre Vascular, Inc.

Trent G. Kamke, Senior VP of Operations at Lemaitre Vascular Inc., reports the acquisition of dividend equivalent rights related to restricted stock unit and performance share unit awards.

Joseph P. Pellegrino JR, CFO of LeMaitre Vascular, reports the acquisition of dividend equivalent rights related to restricted stock unit and performance share unit awards.

David B. Roberts, President and Director of Lemaitre Vascular Inc., reports the acquisition of dividend equivalent rights related to restricted stock unit awards.

George W. LeMaitre, Chairman and CEO of LeMaitre Vascular, reports the acquisition of dividend equivalent rights related to restricted stock unit awards.

LeMaitre Vascular's CEO, George W. LeMaitre, exercised stock options to acquire shares of common stock.

Trent G. Kamke, Senior VP of Operations at Lemaitre Vascular Inc., sold a total of 4,542 shares of common stock on March 8, 2024.

Director John A. Roush of Lemaitre Vascular Inc. (LMAT) sold 7,500 shares of common stock at $69 per share on March 7, 2024.

Director Lawrence Jasinski of Lemaitre Vascular, Inc. (LMAT) sold 5,110 shares of common stock at $67.5 per share on March 5, 2024.

George W. LeMaitre, Chairman and CEO of LeMaitre Vascular, reported multiple transactions involving the company's common stock, including sales and the vesting of Performance Share Units (PSUs).

Joseph P. Pellegrino JR, CFO of LeMaitre Vascular, exercised stock options and sold shares on February 29, 2024, according to a Form 4 filing with the SEC.

Director Lawrence J. Jasinski acquired shares of Lemaitre Vascular through the settlement of a Performance Share Unit (PSU) award and dividend equivalent rights.

John James O'Connor, a director at LeMaitre Vascular, acquired shares of common stock through the settlement of a Performance Share Unit (PSU) award and release of dividend equivalent rights.

Director John A. Roush reports acquiring shares of Lemaitre Vascular Inc. through the settlement of performance share units and dividend equivalent rights.

Director Martha Shadan reports acquisition and disposal of Lemaitre Vascular (LMAT) common stock and dividend equivalent rights related to performance share units.

Director Bridget A. Ross acquired shares of LeMaitre Vascular common stock through the settlement of a Performance Share Unit (PSU) award and release of dividend equivalent rights on February 29, 2024.

David Roberts, a director and officer at Lemaitre Vascular, reports acquisition and disposal of common stock and dividend equivalent rights related to performance share units.

Trent G. Kamke, Senior VP of Operations at Lemaitre Vascular Inc., reports acquisition and disposal of common stock and dividend equivalent rights related to performance share units.